Skip to main content
. 2021 Nov 23;8:749523. doi: 10.3389/fcvm.2021.749523

Table 3.

Univariate analysis for the presence of amyloid deposition.

Parameter Odds ratio 95% CI p-value
Age at death, per year 1.073 0.971–1.186 0.165
Men 1.667 0.570–4.876 0.351
Syncope 2.800 0.798–10.393 0.106
SBP, per mmHg 0.986 0.954–1.018 0.376
Heart failure 4.307 1.290–14.373 0.018
eGFR, per ml/min 0.995 0.972–1.018 0.655
HFpEF 1.636 0.498–5.379 0.417
NYHA 3–4 3.231 0.551–18.956 0.194
Atrial fibrillation 3.896 1.221–12.431 0.022
ECG/echo discrepancy 17.143 3.063–95.938 0.001
Low QRS voltage 11.813 1.329–104.982 0.027
LVEF <40% 1.583 0.274–9.166 0.085
LVEF, per % 0.944 0.885–1.006 0.074
RV dysfunction 1.583 0.274–9.166 0.608
IVS thickness, per mm 1.915 1.219–3.009 0.005
Restrictive filling pattern 5.464 1.256–23.774 0.024
Heart weight, per gr 1.005 1.000–1.010 0.054

CI, Confidence Interval; eGFR, estimated Glomerular Filtration Rate; HFpEF, Heart Failure with Preserved Ejection Fraction; IVS, Interventricular Thickness; LVEF, Left Ventricular Ejection Fraction; NYHA, New York Heart Association; RV, Right Ventricular. Bold identifies significant p values (<0.05).